Dual dopaminergic therapy for tic disorder and Tourette's syndrome

Treatment for tic disorders and Tourette's syndrome focusing on the striosome - Researching effective treatments for tic disorders and Tourette's syndrome.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000055582

Enrollment

Registered

2024-09-23

Start date

2024-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tic disorders and Tourette&#39

Interventions

Prescribe Wintamin and Dopacol for patients with chronic tic disorders who visited our hospital and evaluate their symptoms.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those who meet the diagnostic criteria for Juncos 1. Juncos JL, Freeman A: Pathophysiology and differential diagnosis of tics. In: Watts RL, Koller WC(eds), Movement Disorders. Neurologic Principles and Practice. McGraw-Hill, New York, 1997; 561-568.

Exclusion criteria

Exclusion criteria: Patients deemed ineligible by a physician

Design outcomes

Primary

Measure	Time frame
YGTSS and YBOCS	—

Countries

Japan

Contacts

Public ContactMasahira Kiyota

Osaka Neurological Institute IRB

kiyota@oni.or.jp0663330086

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Dual dopaminergic therapy for tic disorder and Tourette&#39;s syndrome